The HIV diagnostics market encompasses diagnostic screening and confirmatory tests for HIV-1, 2 and group O incidence testing. These tests have primary applications to screen and differentiate between the various groups and subtypes of human immunodeficiency virus.
Owing to the technological development of disease diagnostic tests and the anticipated development and commercialization of novel, regulatory authorities approved POC and rapid CD4, p24 antigen and EID tests, it is expected that all the major regional market segments will witness an increase in market demand over the forecast period.

Market Analysis and Insights: Global HIV Diagnostics Market
The global HIV Diagnostics market size is projected to reach US$ 4697.7 million by 2027, from US$ 2636.2 million in 2020, at a CAGR of 8.5% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global HIV Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global HIV Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global HIV Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global HIV Diagnostics market.

Global HIV Diagnostics Scope and Market Size
HIV Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global HIV Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Consumables
Assay, Kits and Reagents
Other Consumables
Instruments
Software and Services

Segment by Application
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Abbott Healthcare
Abbvie Inc.
Brsitol-Myers Squibb
Janssen Therapeutics
Gilead Sciences
Merck & Co. Inc
VIIV Healthcare
BD Biosciences
Beckman Coulter
Partec
Sysmex
Apogee Flow Systems
PointCare Technologies Inc.
Zyomyx Inc.
Mylan inc.
Roche Diagnostics
Siemens Healthcare
Qiagen
BioMerieux